ReviewCurrent hematologic malignancy reports2006

The JAK2(V617F) tyrosine kinase mutation in myeloproliferative disorders: Summary of published literature and a perspective.

Martha Wadleigh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.